CPR Share Price Performance
€6.47
-1.48 (-18.61%)
29.2% undervalued intrinsic discount
€9.14
Fair Value
Price €6.47
AnalystHighTarget €9.14
AnalystConsensusTarget €6.56
AnalystLowTarget €4.09
Fair Value€9.14
Share Price€6.47
29.2% undervalued intrinsic discount
CPR Community Narratives
AN
Fair Value €9.14 29.2% undervalued intrinsic discount
Aperol And Espolòn Will Flourish Amid Premium Urban Trends
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value €6.56 1.3% undervalued intrinsic discount
Transition To House Of Brands Structure Will Optimize Future Growth Opportunities
0users have liked this narrative
1users have commented on this narrative
32users have followed this narrative
AN
Fair Value €4.09 58.4% overvalued intrinsic discount
Premium Spirits Will Face Declining Demand And Rising Costs
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CPR Community Fair Values
- €6.56FV1.3% undervalued intrinsic discount3.48%Revenue growth p.a.0users have liked this narrative1users have commented on this narrative32users have followed this narrative5 days ago author updated this narrative
- €4.09FV58.4% overvalued intrinsic discount2.42%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative12 days ago author updated this narrative
- €9.14FV29.2% undervalued intrinsic discount6.19%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrative13 days ago author updated this narrative
Recent CPR News & Updates
No updates
Davide Campari-Milano N.V. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 29, 2025
- Earnings per share (EPS)
- 0.16
- Gross Margin
- 58.23%
- Net Profit Margin
- 6.13%
- Debt/Equity Ratio
- 78.2%
Davide Campari-Milano N.V. Competitors
About CPR
- Founded
- 1860
- Employees
- 5218
- CEO
- WebsiteView website
Davide Campari-Milano N.V., together with its subsidiaries, markets and distributes alcoholic and non-alcoholic beverages in the Americas, the Middle East, Africa, Europe, and the Asia-Pacific. It offers a range of spirits products, including aperitifs, vodka, liqueurs, bitters, whisky, tequila, rum, gin, cognac, champagne, and non-alcoholic aperitifs under the Aperol, Campari, Espolòn, Wild Turkey, Jamaican rums, Grand Marnie, SKYY, Sparkling Wines, Champagne & Vermouth, Crodino, Magnum Tonic, Aperol Spritz RTE, Italian specialities, The GlenGrant, Campari Soda, Ouzo, X-Rated, and other brand names. Davide Campari-Milano N.V. was founded in 1860 and is headquartered in Sesto San Giovanni, Italy. Davide Campari-Milano N.V. operates as a subsidiary of Lagfin S.C.A.
Italian Market Performance
- 7 Days: -0.4%
- 3 Months: 4.6%
- 1 Year: 27.1%
- Year to Date: 16.3%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 9.3%. As for the longer term, the market has risen 27% in the past 12 months. Looking forward, earnings are forecast to grow by 8.2% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading